In order to conduct a case-control study, we first selected 3739 female patients with unifocal invasive BC, T1b, or T1c N0M0, expressing ER without amplification of HER2, and treated by primary surgery between 2003 and 2010 (Additional File 1: Fig. S1). This evidence concerns the gene ERBB2 and breast cancer.